Enhabit Secures $43.1M in Executive Fiduciary Breach Case

DALLAS, TX – February 12, 2026 – Enhabit, Inc. and its former parent company, Encompass Health Corporation, have collected $43.1 million in a significant settlement tied to a landmark corporate loyalty case. The payment fully resolves claims for attorneys' fees and damages against a former officer and two private equity partners involved in what a Delaware court described as “egregious breaches of the duty of loyalty.”

This multimillion-dollar recovery stems from a December 2024 court judgment that found senior executives of Encompass Health’s former home health and hospice division—which now operates as Enhabit—had secretly worked to establish a competing company. The settlement proceeds, which will be divided almost equally between Enhabit and Encompass Health, mark a pivotal moment in a protracted legal battle that has cast a harsh light on executive conduct and private equity involvement in the healthcare sector. The payment was made by former officer Chris Walker, Vistria Group senior partner David Schuppan, and Nautic Partners managing director Christopher Corey.

While this settlement closes the chapter on specific monetary damages from the individuals, it leaves intact the most substantial part of the court's original ruling: a constructive trust that entitles Enhabit and Encompass Health to a massive 43% share of all future profits and exit proceeds from the rival company, VitalCaring Group.

Anatomy of a Corporate Betrayal

The case unraveled a carefully orchestrated scheme by high-level executives to betray their employer. The Delaware Court of Chancery’s 2024 ruling detailed how April Anthony, Luke James, and Chris Walker, while still in senior leadership roles at Encompass Health, systematically diverted corporate opportunities, utilized confidential information, and poached key employees to build their new venture.

The court found that the executives, entrusted with guiding the nation's largest home health and hospice business, instead worked against it. They usurped acquisition opportunities that rightfully belonged to Encompass and leveraged proprietary data to inform the strategy of their nascent competitor. The court documents reveal a concerted effort to conceal their activities, with the defendants taking what the court called “great pains” to cover their tracks.

This deception included using coded language in communications—reportedly referring to lead executive April Anthony as “Voldemort”—to avoid detection. The court also found evidence of falsified records, the creation of sham employee recruitment processes to mask the poaching of Encompass staff, and the deliberate deletion of communications. The judgment concluded that VitalCaring Group was, in essence, “the result of this deceit,” built on a foundation of disloyalty and misappropriated resources.

The Role of Private Equity

The court's findings did not stop with the former executives. The judgment also held private equity firms The Vistria Group and Nautic Partners accountable for their role in the scheme, concluding they had aided and abetted the executives' breaches of fiduciary duty. The firms’ partners, David Schuppan of Vistria and Christopher Corey of Nautic, were identified as having “drove the fiduciaries’ efforts to covertly siphon opportunities, information, resources, and employees from Encompass.”

According to the court, these private equity players were not passive investors but active participants in the misconduct. They secretly partnered with Anthony, James, and Walker to finance and structure VitalCaring Group, with full knowledge of the executives' ongoing obligations to Encompass Health. The resulting ownership structure of VitalCaring Group divided the company into three equal parts: one-third for April Anthony, one-third for The Vistria Group, and one-third for Nautic Partners.

The ruling against the private equity firms sends a powerful signal to the investment community, particularly those active in the healthcare space. It underscores that liability for corporate malfeasance can extend beyond rogue executives to the financial backers who knowingly facilitate and encourage such breaches for their own gain.

A Two-Part Victory: Cash Now, Profits Later

The resolution of the case provides a dual financial victory for Enhabit and Encompass Health. The immediate infusion of $43.1 million, split between them, offers a tangible recovery of the costs incurred in litigation and mitigating the damages caused by the executives' actions. This settlement provides a significant boost to their respective balance sheets.

However, the more profound financial remedy lies in the constructive trust, which remains fully in effect. This court-ordered mechanism effectively makes Enhabit and Encompass Health major stakeholders in their rival's future success. They are now entitled to 43% of all ongoing profits generated by VitalCaring Group, payable quarterly, as well as 43% of the proceeds from any future sale of the company.

At the time of the judgment, VitalCaring had not yet achieved profitability. However, the court astutely structured the trust to ensure all parties remained motivated. By leaving the private equity backers and their executive partners with a 57% majority share, the court reasoned that they would still be incentivized to grow the business and generate returns on their investment. This arrangement positions Enhabit and Encompass to reap substantial, long-term financial rewards from the very enterprise that was created to compete against them.

Setting a Precedent for Corporate Governance

Beyond the financial implications, the case stands as a landmark decision on corporate governance and executive accountability. The Delaware Court of Chancery, a leading venue for corporate law in the United States, used the ruling to send what it called a “clear message” that intentional self-dealing and disloyalty by corporate officers will not be tolerated.

The judgment reinforces the fundamental principle that an executive's primary duty is to their employer, and any attempt to divert corporate opportunities for personal enrichment constitutes a severe breach of that trust. The significant penalties imposed—including the disgorgement of future profits through the constructive trust—serve as a potent deterrent for others who might contemplate similar actions.

The legal and business communities have watched the case closely, recognizing its potential to influence future litigation involving fiduciary duties, especially in the context of private equity-backed ventures and executive transitions. The outcome reaffirms that the legal system can and will impose severe consequences for calculated corporate betrayal, ensuring that the fruits of such misconduct are returned to the rightful owners.